InspireMD (NSPR) Return on Sales (2016 - 2025)
InspireMD's Return on Sales history spans 16 years, with the latest figure at 8.67% for Q4 2025.
- For Q4 2025, Return on Sales fell 27.0% year-over-year to 8.67%; the TTM value through Dec 2025 reached 1.14%, down 18.0%, while the annual FY2025 figure was 5.43%, 87.0% down from the prior year.
- Return on Sales reached 8.67% in Q4 2025 per NSPR's latest filing, up from 5.17% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 8.94% in Q4 2024 to a low of 7.5% in Q1 2025.
- Average Return on Sales over 5 years is 2.92%, with a median of 3.58% recorded in 2023.
- Peak YoY movement for Return on Sales: soared 2060bps in 2021, then crashed -259bps in 2025.
- A 5-year view of Return on Sales shows it stood at 2.94% in 2021, then plummeted by -60bps to 4.69% in 2022, then increased by 30bps to 3.3% in 2023, then soared by 371bps to 8.94% in 2024, then decreased by -3bps to 8.67% in 2025.
- Per Business Quant, the three most recent readings for NSPR's Return on Sales are 8.67% (Q4 2025), 5.17% (Q3 2025), and 7.32% (Q2 2025).